Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1630-4
Abstract: IntroductionPercutaneous hepatic perfusion (PHP) with melphalan is an effective treatment for patients with hepatic metastases, but associated with high rates of bone marrow depression. To reduce systemic toxicity, improvements have been made to the filtration… read more here.
Keywords: system; hepatic perfusion; melphalan; gen2 ... See more keywords
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1766-2
Abstract: Introduction Percutaneous hepatic perfusion (PHP) with melphalan is an effective treatment for patients with hepatic metastases, but associated with high rates of bone marrow depression. To reduce systemic toxicity, improvements have been made to the… read more here.
Keywords: system; hepatic perfusion; delcath system; melphalan ... See more keywords
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers
Sign Up to like & getrecommendations! Published in 2021 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-021-02983-2
Abstract: Chemosaturation (CS; CHEMOSAT®, Delcath Systems Inc.) temporarily administers melphalan into the liver by percutaneous hepatic perfusion (PHP). CS-PHP can effectively control growth in liver tumors, but efficacy and tolerability of sequential treatments are unclear. We… read more here.
Keywords: response; hepatic perfusion; long term; percutaneous hepatic ... See more keywords
Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical science"
DOI: 10.1042/cs20171131
Abstract: The purpose of the present study was to develop and perform initial validation of dynamic MRI enhanced with gadoxetic acid as hepatobiliary contrast agent to quantify hepatic perfusion and hepatocyte function in patients with chronic… read more here.
Keywords: hepatic perfusion; perfusion; gadoxetic acid; hepatocyte function ... See more keywords
Hepatic perfusion as a new predictor of prognosis and mortality in critical care patients with acute-on-chronic liver failure
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.1008450
Abstract: Background and aims Liver diseases are frequent causes of morbidity and mortality worldwide. Liver diseases can lead to cirrhosis, with the risk of acute-on-chronic liver failure (ACLF). For the detection of changes in hepatic hemodynamics,… read more here.
Keywords: liver; delta; liver failure; hepatic perfusion ... See more keywords